Structure-function relationship between corneal nerves and conventional small-fiber tests in type 1 diabetes

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2748-2755

  Sivaskandarajah, Gavasker A ^a   Halpern, Elise M ^a   Lovblom, Leif E ^a   Weisman, Alanna ^a   Orlov, Steven ^a   Bril, Vera ^a   Perkins, Bruce A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ACTION POTENTIAL; ADULT; AGE; ARTICLE; BLOOD PRESSURE; BRANCH DENSITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; COOLING DETECTION THRESHOLD; CORNEA; CORNEAL NERVE FIBER LENGTH; CORNEAL NERVE STRUCTURE; DIABETIC NEUROPATHY; DIABETIC SENSORIMOTOR POLYNEUROPATHY; DISEASE DURATION; FEMALE; FIBER DENSITY; FIBER TORTUOSITY; HEART RATE VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IN VIVO CORNEAL CONFOCAL MICROSCOPY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NERVE FIBER; STRUCTURE ACTIVITY RELATION; VASODILATATION; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; CORNEA; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; YOUNG ADULT;

EID: 84891823554     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2075     Document Type: Article

References (39)

1. Boulton AJM, Vinik AI, Arezzo JC, et al.; American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28: 956-962
2. Tesfaye S, Chaturvedi N, Eaton SE, et al.; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352: 341-350
3. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13: 513-521
4. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl JMed 1995;333: 89-94
5. Dyck PJ, Bushek W, Spring EM, et al. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 1987;10: 432-440
6. Gruener G, Dyck PJ. Quantitative sensory testing: methodology, applications, and future directions. J Clin Neurophysiol 1994;11: 568-583
7. Suarez G, Dyck PJ. Quantitative sensory assessment. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Eds. Philadelphia, W.B. Saunders, 1999, p. 151-169
8. Stålberg EV, Nogués MA. Automatic analysis of heart rate variation: I. Method and reference values in healthy controls. Muscle Nerve 1989;12: 993-1000
9. Orlov S, Bril V, Orszag A, Perkins BA. Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes. Diabetes Care 2012;35: 809-816
10. Krishnan ST, Rayman G. The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 2004;27: 2930-2935
11. Krishnan ST, Quattrini C, Jeziorska M, Malik RA, Rayman G. Abnormal LDIflare but normal quantitative sensory testing and dermal nerve fiber density in patients with painful diabetic neuropathy. Diabetes Care 2009;32: 451-455
12. Vas PRJ, Green AQ, Rayman G. Small fibre dysfunction, microvascular complications and glycaemic control in type 1 diabetes: a case-control study. Diabetologia 2012; 55: 795-800
13. Zinman LH, Bril V, Perkins BA. Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. Diabetes Care 2004;27: 1674-1679
14. Tesfaye S, Boulton AJ, Dyck PJ, et al.; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33: 2285-2293
15. Malik RA, Kallinikos P, Abbott CA, et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003;46: 683-688
16. Tavakoli M, Kallinikos PA, Efron N, Boulton AJ, Malik RA. Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diabetes Care 2007;30: 1895-1897
17. Rosenberg ME, Tervo TM, Immonen IJ, Müller LJ, Grönhagen-Riska C, Vesaluoma MH. Corneal structure and sensitivity in type 1 diabetesmellitus. Invest Ophthalmol Vis Sci 2000;41: 2915-2921
18. Ahmed A, Bril V, Orszag A, et al.Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study. Diabetes Care 2012;35: 821-828
19. Hertz P, Bril V, Orszag A, et al. Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med 2011;28: 1253-1260
20. Wu T, Ahmed A, Bril V, Orszag A, Ng E, Nwe P, Perkins BA. Variables associated with corneal confocal microscopy parameters in healthy volunteers: implications for diabetic neuropathy screening. Diabet Med 2012;29:e297- e303
21. Patel DV, Tavakoli M, Craig JP, Efron N, McGhee CN. Corneal sensitivity and slit scanning in vivo confocal microscopy of the subbasal nerve plexus of the normal central and peripheral human cornea. Cornea 2009;28: 735-740
22. Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 2007;30: 2608-2612
23. Quattrini C, Tavakoli M, Jeziorska M, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 2007;56: 2148-2154
24. Edwards K, Pritchard N, Vagenas D, Russell A, Malik RA, Efron N. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin Exp Optom 2012;95: 348-354
25. Casanova-Molla J, Grau-Junyent JM, Morales M, Valls-Solé J. On the relationship between nociceptive evoked potentials and intraepidermal nerve fiber density in painful sensory polyneuropathies. Pain 2011;152: 410-418
26. Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 2002;25: 2048-2052
27. Nabavi Nouri M, Ahmed A, Bril V, et al. Diabetic neuropathy and axon reflexmediated neurogenic vasodilatation in type 1 diabetes. PLoS ONE 2012;7:e34807
28. England JD, Gronseth GS, Franklin G, et al.; American Academy of Neurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64: 199-207
29. Shin TM, Bril V, Orszag A, Ahmed A, Perkins BA. How sensitive is the case definition for diabetic sensorimotor polyneuropathy to the use of different symptoms, signs, and nerve conduction parameters in type 1 diabetes?Diabetes ResClin Pract 2011; 92:e16-e19
30. Oh SJ. Normal values for common nerve conduction tests. In Clinical Electromyography: Nerve Conduction Studies. Philadelphia, Lipincott Williams & Wilkins, 2003, p. 86-106
31. Kallinikos P, Berhanu M, O'Donnell C, Boulton AJ, Efron N, Malik RA. Corneal nerve tortuosity in diabetic patients with neuropathy. Invest Ophthalmol Vis Sci 2004;45: 418-422
32. England JD, Gronseth GS, Franklin G, et al.; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72: 177-184
33. Efron N, Edwards K, Roper N, et al. Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetes. Eye Contact Lens 2010;36: 245-248
34. Tavakoli M, Quattrini C, Abbott C, et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 2010;33: 1792-1797
35. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
36. Vagenas D, Pritchard N, Edwards K, et al. Optimal image sample size for corneal nervemorphometry.Optom Vis Sci 2012; 89: 812-817
37. Ziegler D, Luff D. Clinical trials for drugs against diabetic neuropathy: can we combine scientific needs with clinical practicalities? Int Rev Neurobiol 2002; 50: 431-463
38. Magda P, Latov N, Renard MV, Sander HW. Quantitative sensory testing: high sensitivity in small fiber neuropathy with normal NCS/EMG. J Peripher Nerv Syst 2002;7: 225-228
39. Gibbons CH, Illigens BM, Wang N, Freeman R. Quantification of sweat gland innervation: a clinical-pathologic correlation. Neurology 2009;72: 1479-1486